Screener
Cytokinetics CYTK Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$198.76M-47.9% | -$206.03M-27.7% | -$183.03M-22.0% | -$306.18M-90.7% | -$134.37M+6.2% | ||
| $3.63M+58.9% | $3.38M+46.9% | $2.86M+20.1% | $2.68M+11.1% | $2.29M-5.0% | ||
| $35.71M+29.7% | $30.39M+29.1% | $30.51M+16.2% | $30.7M+21.1% | $27.54M+11.8% | ||
| -$159.84M-24.6% | -$145.46M-10.5% | -$142.65M-118% | -$107.51M-5.9% | -$128.24M-29.1% | ||
| $4.33M+4.6% | $5.93M+4.7% | $5.64M+338% | $9.35M+1,234% | $4.15M+116% | ||
| -$507M-1,059% | $145.49M+37.3% | —— | —— | $52.88M+108% | ||
| $3.59M+33.3% | $2.74M+2.0% | $2.72M+1.9% | $2.71M+1.9% | $2.7M+1.9% | ||
| $792.86M+910% | $7.77M+63.4% | $110.71M+4,544% | $330.47M+9,549% | $78.53M-90.4% | ||
| $125.42M— | $7.32M+135% | —— | $152.03M+206% | —— | ||
| -$164.17M-24.0% | -$151.39M-10.3% | -$148.3M-122% | -$116.86M-14.3% | -$132.38M-30.8% |
FAQ
- How much cash does Cytokinetics generate?
- Cytokinetics (CYTK) generated -$555.5M in operating cash flow over the trailing twelve months.
- What is Cytokinetics's free cash flow?
- After $25.3M of capital expenditures, Cytokinetics's free cash flow was -$580.7M over the trailing twelve months, down 32.4% year over year.
- Where does Cytokinetics's cash flow data come from?
- Every line is extracted from Cytokinetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
